Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
In vitro fertilisation does not increase the risk of ovarian cancer
A new paper in JNCI: Journal of the National Cancer Institute indicates that receiving assisted reproductive…
Cancer metastasis: From problem to opportunity
When a patient with cancer is told the devastating news that their disease has spread,…
Improving Treatment for Metastatic Breast Cancer
Research led by Peter Mac is helping explain the broader effects of a new and…
Nine US deaths linked to breast implant-associated cancer
Nine women are believed to have died in the United States from a rare cancer linked to breast implants, US…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.